Asia-Pacific Insulin Delivery Devices Market – Industry Trends and Forecast to 2027

  • Drug Delivery Devices
  • Upcoming Report
  • Oct 2020
  • Asia-Pacific
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

Asia-Pacific Insulin Delivery Devices Market By Product Type (Insulin Syringes, Insulin Pens, Insulin Pumps, Pen Needles, Insulin Syringes, Insulin Injectors), End User (Homecare, Hospitals, Clinics, Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific) Industry Trends and Forecast to 2027

Asia-Pacific Insulin Delivery Devices Market Market Analysis and Insights : Asia-Pacific Insulin Delivery Devices Market

Insulin delivery devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 6.00 billion by 2027 growing at a CAGR of 9.08% in the above-mentioned forecast period. The growing diabetes diseases among the patients will help in driving the growth of the insulin delivery devices market.

Conferences, meetings and congresses to create awareness about insulin delivery devices, favorable reimbursement environment and government support in selected countries and technological advancements in insulin delivery devices will likely to accelerate the growth of the insulin delivery devices market in the forecast period of 2020-2027. On the other hand, growing diabetes-related health expenditure in emerging economies and safety needles will further boost various opportunities that will lead to the growth of the insulin delivery devices market in the above-mentioned forecast period. 

Oral insulin as an alternative drug delivery method and issues associated with the reuse of pen needles and infusion sets will likely to hamper the growth of the insulin delivery devices market in the above-mentioned forecast period. 

The severe shortage of endocrinologists is going to pose a serious challenge for the insulin delivery devices market.

This insulin delivery devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on insulin delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Insulin Delivery Devices Market Scope and Market Size

Insulin delivery devices market is segmented on the basis of product type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on product type, the insulin delivery devices market is segmented into insulin syringes, insulin pens, insulin pumps, pen needles, insulin syringes and insulin injectors. The insulin pens are further sub-segmented into reusable and disposable. The insulin pumps are further sub-segmented into external/tethered and patch. The pen needles are further sub-segmented into standard and safety.
  • Insulin delivery devices market has also been segmented based on the end user into homecare, hospitals, clinics and others

Insulin Delivery Devices Market Country Level Analysis

Insulin delivery devices market is analysed and market size insights and trends are provided by country, product type and end user as referenced above.

The countries covered in the insulin delivery devices market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC).

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 with China leading as a top country due to developing economies in terms of GDP, presence of a large population base suffering with diabetes and its rising awareness amongst individuals.

The country section of the insulin delivery devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Insulin Delivery Devices Market Share Analysis

Insulin delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to insulin delivery devices market.

The major players covered in the insulin delivery devices market report are BD, Medtronic, Ypsomed, Novo Nordisk India Pvt Ltd, Beta Bionics, Owen Mumford Ltd., Sanofi, Tandem Diabetes Care, Inc., Copernicus, Dance Biopharm Holdings Inc., Insulet Corporation, Biocon, Eli Lilly, West Pharmaceutical Services, Inc., F. Hoffmann-La Roche Ltd, Debiotech S.A, InsuJet, SHL Group, SOOIL Developments Co., Ltd among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Asia-Pacific Insulin Delivery Devices Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions